Open this publication in new window or tab >>Show others...
2024 (English)In: Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, E-ISSN 1879-1220, Vol. 240, article id 106497Article in journal (Refereed) Published
Abstract [en]
The active form of vitamin D, 1,25-dihydroxyvitamin D3, is known to act via VDR (vitamin D receptor), affecting several physiological processes. In addition, PDIA3 (protein disulphide-isomerase A3) has been associated with some of the functions of 1,25-dihydroxyvitamin D3. In the present study we used siRNA-mediated silencing of PDIA3 in osteosarcoma and prostate carcinoma cell lines to examine the role(s) of PDIA3 for 1,25-dihydroxyvitamin D3-dependent responses. PDIA3 silencing affected VDR target genes and significantly altered the 1,25-dihydroxyvitamin D3-dependent induction of CYP24A1, essential for elimination of excess 1,25-dihydroxyvitamin D3. Also, PDIA3 silencing significantly altered migration and proliferation in prostate PC3 cells, independently of 1,25-dihydroxyvitamin D3. 1,25-Dihydroxyvitamin D3 increased thermostability of PDIA3 in cellular thermal shift assay, supporting functional interaction between PDIA3 and 1,25-dihydroxyvitamin D3-dependent pathways. In summary, our data link PDIA3 to 1,25-dihydroxyvitamin D3-mediated signalling, underline and extend its role in proliferation and reveal a novel function in maintenance of 1,25-dihydroxyvitamin D3 levels.
Place, publisher, year, edition, pages
Elsevier, 2024
Keywords
PDIA3, 1, 25-dihydroxyvitaminD3, Cellular proliferation, VDR
National Category
Biochemistry Molecular Biology
Identifiers
urn:nbn:se:uu:diva-528689 (URN)10.1016/j.jsbmb.2024.106497 (DOI)001222646600001 ()38460707 (PubMedID)
Funder
Swedish Foundation for Strategic Research, SB16-0039Swedish Cancer Society, 19 0135Swedish Cancer Society, 21 1427 Pj 01HSwedish Research Council, 2017-01775
2024-05-312024-05-312025-08-12Bibliographically approved